Cardiovascular Rounds

News, resources, and analysis from the Cardiovascular Roundtable

CV providers are referring to palliative care less often—how can you reverse the trend?

by Daniel Roza September 24, 2019

Health systems face more pressure than ever to improve quality and cut costs. However, the adoption of palliative care, long shown to be an effective means of improving long-term patient outcomes, actually seems to be falling in CV service lines: A study recently published in JAMA shows that the proportion of cardiologists referring patients for palliative care between 2015 and 2017 dropped by 6.5% to a mere 10.5%, and that referrals for CV patients lagged behind those for patients with other diseases. As the push to value-based care accelerates, the CV service line needs a course correction. Here's why palliative care should be a priority at your program—and how to incorporate it into daily CV care.

Read more »

4 ways FDA's approval of low-risk TAVR will affect your CV program

Megan Tooley September 10, 2019

On August 16, 2019, FDA approved transcatheter aortic valve replacement (TAVR) in severe aortic stenosis patients at low-risk for surgery. This was a highly-anticipated move following the compelling results of low-risk TAVR trials presented earlier this year at the American College of Cardiology Scientific Session. Unlike previous indication expansions, FDA approved both the Medtronic and Edwards valves at once.

Read more »

CV takeaways from the FY 2020 inpatient final rule

by Megan Tooley and Jordan Sanford August 9, 2019

On August 2, CMS released the fiscal year (FY) 2020 final rule for the inpatient prospective payment systems (IPPS). Among the rule's nearly 2,300 pages are some major changes that CV leaders should know as they plan for the year ahead, including updates to extracorporeal membrane oxygenation (ECMO) and transcatheter structural heart procedure coding.

Read more »

2 need-to-know CV takeaways from the 2020 HOPPS proposed rule

Julie Bass August 2, 2019

On Monday, CMS released its proposed payment and regulatory updates for hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs) in calendar year (CY) 2020.

Read more »

What CV leaders need to know about the 2020 proposed IPPS rule

by Megan Tooley and Daniel Roza May 8, 2019

Last week CMS released the fiscal year (FY) 2020 proposed rule for the inpatient prospective payment systems (IPPS). Among the rule's nearly 2,000 pages are some major changes CV leaders should know about as they plan for the year ahead, including updates to extracorporeal membrane oxygenation (ECMO) and transcatheter structural heart procedure coding. Here are our insights on how these changes may affect your program.

Read more »

How 2 health systems are reimagining cardio-oncology care

by Liam Frieswick and Daniel Roza April 24, 2019

Editor's note: This story was updated on May 6, 2019.

Thanks to improvements in early detection and treatment, the number of cancer survivors is increasing. However, as cancer death rates decline, many more patients are developing other acute and chronic conditions—indeed, cardiovascular (CV) disease is now the second-most common cause of long-term morbidity and mortality among cancer patients. In light of these trends, systems need to plan strategically to identify and deliver high value care to patients in need of both cardiovascular and oncological services.

Read more »

What MitraClip's indication expansion means for your CV program

Megan Tooley March 15, 2019

On March 14, 2019, FDA made the much-anticipated announcement that it has expanded indications for the MitraClip device to heart failure patients who also have moderate to severe mitral regurgitation (MR).

Read more »

The 3 market dynamics affecting CV imaging

by Emily Snow and Matthew Morrill February 27, 2019

Advisory Board data suggest significant growth for most cardiac imaging modalities across the next five years—nearly three times higher than non-cardiac imaging—driven by demographic change, technological innovation, and the push for early identification under population health models. However, cardiovascular (CV) and imaging programs face competing priorities when balancing growth aspirations with the need for appropriate utilization and threats to reimbursement.

Read more »

Comment Now

You must be logged in to comment